Oral Treatment for Inflammatory Bowel Disease Doses First Patients in Phase 1 Trial
As reported in BioSpace; trials for an oral treatment to treat inflammatory bowel disease (IBD) by Morphic Therapeutics has just dosed their first healthy subjects in the Phase 1 trial.…